Ara
Toplam kayıt 23, listelenen: 11-20
Factor XIII Val34Leu polymorphism in patients with cardiac syndrome X
(Via Medica Journals, 2014)
Background: The aim of the study was to examine the frequency of factor XIII polymorphism among patients with cardiac syndrome X (CSX). Methods: This study was designed as a cross-sectional and observational study. Forty-eight ...
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
(Lippincott Williams & Wilkins, 2016)
This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life ...
Predictors of right ventricular systolic dysfunction in non-ischemic dilated cardiomyopathy: An echocardiographic study
(Shiraz Univ Medical Sciences, Cardiovascular Research Center, 2016)
Background: Right Ventricular (RV) functions are known to have an impact on determining the prognosis of patients with Non-Ischemic Dilated Cardiomyopathy (NICMP). Objectives: This study aimed to investigate the echocardiographic ...
Adding lipoprotein(a) levels to the GRACE score to predict prognosis in patients with non-ST elevation acute coronary syndrome
(Via Medica, 2013)
Background: High levels of lipoprotein(a) [Lp(a)] are known to be a cardiovascular risk factor associated with premature coronary artery disease. In predicting the long term prognosis in acute coronary syndromes (ACS), the ...
Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds
(Wiley, 2017)
Objectives: We aimed to evaluate the peri-procedural success of DESolve bio-resorbable scaffolds (BRSs) and analyzed real-life data about major cardiac events during 1-year follow-up. Background: There is little information ...
Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from ramses study
(Elsevier B.V., 2017)
Objective No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate ...
The relationship between the S-wave in lead 1 and recurrence of RVOT PVC ablation
(Churchill Livingstone Inc Medical Publishers, 2018)
Background: Radiofrequency catheter ablation (CA) is a common non-pharmacological treatment option for ventricular premature contractions (PVCs) originating from right ventricular outflow tract (RVOT). In this study, we ...
Giant left ventricular pseudoaneurysm concomitant with severe mitral regurgitation: Multimodality imaging and successful surgical repair
(Oxford University Press, 2015)
A 58-year old man with previous myocardial infarction was shown to have a huge pseudoaneurysm (8 × 6 cm) on the left ventricular posterior wall concomitant with severe mitral regurgitation. The left ventricle was reconstructed ...
Hemopericardium and cardiac tamponade in a patient treated with dabigatran etexilate
(Korean Soc Cardiology, 2016)
Dabigatran etexilate is one of the new oral anticoagulants approved to reduce the risk of stroke in patients with atrial fibrillation (AF). A variety of bleeding complications with dabigatran have been reported, but reports ...
Adjusting the QRS duration by body mass index for prediction of response to cardiac resynchronization therapy: Does one QRS size fit all?
(Wiley, 2016)
Background: QRS duration (QRSd) is known to be affected by body weight and length. We tested the hypothesis that adjusting the QRSd by body mass index (BMI) may provide individualization for patient selection and improve ...